Edelweiss has come out with its top picks report. Alembic Pharma, Bajaj Finance, ICICI Bank, Larsen & Toubro, Lupin, Maruti Suzuki India, Motherson Sumi Systems, Pidilite Industries, Sobha Developers, The Ramco Cements, Wipro and Zee Entertainment Enterprises are the 12 stocks in the list.
Firstcall Research is bullish on Alembic Pharma and has recommended buy rating on the stock with a target of Rs 160 in its September 12, 2013 research report.
Brokerage house Nirmal Bang has recommended hold rating on Alembic Pharmaceuticals with a price target of Rs 181 in its August 13, 2013 research report.
Sushil Finance is bullish on Alembic Pharmaceuticals (APL) and has recommended buy rating on the stock with a target price of Rs 153 in its May 07, 2013 research report.
Nirmal Bang is bullish on Alembic Pharma and has recommended buy rating on the stock with a target price of Rs 119, in its March 05, 2013 research report.
Angel Broking is bullish on Alembic Pharma and has recommended buy rating on the stock with a target of Rs 95 in its January 22, 2013 research report.
Sushil Finance is bullish on Alembic Pharma and has recommended accumulate rating on the stock with a target of Rs 79 in its January 23, 2013 research report.
The Indian equity markets are witnessing renewed confidence on positive global and domestic policy actions.
Angel Broking is bullish on Alembic Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 91 in its October 19, 2012 research report.
Angel Broking is bullish on Alembic Pharma and has recommended buy rating on the stock with a target of Rs 91 in its August 10, 2012 research report.
Nirmal Bang is bullish on Alembic Pharma and has recommended buy rating on the stock with a target of Rs 86 in its May 2, 2012 research report.
Angel Broking is bullish on Alembic Pharma and has recommended buy rating on the stock with a target of Rs 91 in its April 25, 2012 research report.
Angel Broking is bullish on Alembic Pharma and has recommended buy rating on the stock with a target of Rs 82 in its February 10, 2012 research report.
Angel Broking is bullish on Alembic Pharma and has recommended buy rating on the stock with a target price of Rs 77 in its November 2, 2011 research report.